Thus, Ferrandi et al. [34] postulate that skeletal muscle may be impacted by COVID-19 through direct infection of resident ACE2-rich cell types and/or indirectly through systemic cytokine release and subsequent homeostatic perturbation. The gene discussed is ACE2; the disease is COVID-19.